Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q3 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.